Do Immunogen, Inc. (NASDAQ: IMGN) Fit In A Value Investing Philosophy?
Currently, there are 279.35M common shares owned by the public and among those 272.92M shares have been available to trade. Insiders at the company have transacted a total of 81 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Growing Through Challenges? – Immunogen, Inc. (IMGN)
Currently, there are 279.35M common shares owned by the public and among those 273.02M shares have been available to trade. Insiders at the company have transacted a total of 81 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Immunogen, Inc. (NASDAQ: IMGN): Reassessing Prospects
Immunogen, Inc. (IMGN) concluded trading on Wednesday at a closing price of $29.32, with 5.86 million shares of worth about $171.74 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 60.70% during that period and on Wednesday, January 31 the price saw a loss […]
Do Immunogen, Inc. (NASDAQ: IMGN) Fit In A Value Investing Philosophy?
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 8.57% valued currently at $709.08 million. In addition, Janus […]
Immunogen, Inc. (IMGN) Volatility Spurs A Quest For Clarity
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 8.98% valued currently at $701.91 million. In addition, Janus […]
Immunogen, Inc. (NASDAQ: IMGN): Hunting Genuine Value In Market Debris
The Vanguard Group, Inc. recently announced the acquisition of new stake in Immunogen, Inc. (NASDAQ:IMGN). The institutional investor has increased its shareholding in the Healthcare company by 17.35% to 23.92 million shares with purchase of 3.54 million shares. This fresh investment now brings its stake to 8.98% valued currently at $701.91 million. In addition, Janus […]
